Keywords: Muscle, Quantitative Imaging
Motivation: Duchenne muscular dystrophy (DMD) leads to progressive muscle degeneration, yet reliable biomarkers to monitor disease progression over time are limited.
Goal(s): To evaluate DMD disease progression using qMRI and compare the responsiveness of imaging indicators with clinical function scales.
Approach: Patients underwent gluteal muscle MRI for fat fraction (FF) and T1 relaxation time. Motor function was evaluated using the North Star Ambulatory Assessment (NSAA) and timed functional tests, with standardized response mean (SRM) measuring disease progression responsiveness.
Results: The overall SRM of MRI biomarkers is higher than that of the clinical function scales, and their sensitivity indicators vary with the disease stages.
Impact: The high sensitivity of MRI biomarkers to subtle muscle changes enables early detection of pathology, making it a valuable tool for tracking disease progression from subclinical to symptomatic stages.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords